These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11884987)
1. [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia]. Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H Dtsch Med Wochenschr; 2002 Mar; 127(10):492-6. PubMed ID: 11884987 [TBL] [Abstract][Full Text] [Related]
2. [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis]. Bandrés Gimeno R; Muñoz Martínez MJ Arch Bronconeumol; 2007 Jan; 43(1):49-51. PubMed ID: 17257565 [TBL] [Abstract][Full Text] [Related]
3. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Sambatakou H; Dupont B; Lode H; Denning DW Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972 [TBL] [Abstract][Full Text] [Related]
4. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732 [TBL] [Abstract][Full Text] [Related]
5. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Glackin L; Leen G; Elnazir B; Greally P Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017 [TBL] [Abstract][Full Text] [Related]
6. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature. Kaffarnik M; Utzolino S; Blaich A; Hopt UT Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600 [TBL] [Abstract][Full Text] [Related]
7. The treatment of pulmonary aspergilloma. Judson MA; Stevens DA Curr Opin Investig Drugs; 2001 Oct; 2(10):1375-7. PubMed ID: 11890350 [TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis in a tertiary-care hospital in Thailand. Kiertiburanakul S; Thibbadee C; Santanirand P J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043 [TBL] [Abstract][Full Text] [Related]
9. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. Erwin GE; Fitzgerald JE J Asthma; 2007 Dec; 44(10):891-5. PubMed ID: 18097869 [TBL] [Abstract][Full Text] [Related]
10. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Chow L; Brown NE; Kunimoto D Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. Stevens DA; Schwartz HJ; Lee JY; Moskovitz BL; Jerome DC; Catanzaro A; Bamberger DM; Weinmann AJ; Tuazon CU; Judson MA; Platts-Mills TA; DeGraff AC N Engl J Med; 2000 Mar; 342(11):756-62. PubMed ID: 10717010 [TBL] [Abstract][Full Text] [Related]
12. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. Jain LR; Denning DW J Infect; 2006 May; 52(5):e133-7. PubMed ID: 16427702 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Borlenghi E; Cattaneo C; Capucci MA; Pan A; Quaresmini G; Franco F; Grazioli L; Carosi GP; Rossi G Ann Hematol; 2007 Mar; 86(3):205-10. PubMed ID: 17119965 [TBL] [Abstract][Full Text] [Related]
15. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ; Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256 [TBL] [Abstract][Full Text] [Related]
16. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234 [TBL] [Abstract][Full Text] [Related]
18. Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised? Hachem R; Sumoza D; Hanna H; Girgawy E; Munsell M; Raad I Cancer; 2006 Apr; 106(7):1581-6. PubMed ID: 16475153 [TBL] [Abstract][Full Text] [Related]
19. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole]. Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288 [TBL] [Abstract][Full Text] [Related]